Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 543.60M | $ 445.80M | $ 773.60M | $ 240.10M | $ 185.00M |
Total Assets | $ 2.82B | $ 2.52B | $ 3.18B | $ 2.71B | $ 2.92B |
Total Debt | $ 1.69B | $ 1.60B | $ 2.25B | $ 2.27B | $ 2.23B |
Net Debt | $ 1.15B | $ 1.15B | $ 1.48B | $ 2.03B | $ 2.04B |
Total Liabilities | $ 2.51B | $ 2.24B | $ 2.87B | $ 2.77B | $ 2.72B |
Stockholders Equity | $ 225.00M | $ 211.90M | $ 240.30M | $ -116.00M | $ 130.10M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |